<SEC-DOCUMENT>0001104659-24-124097.txt : 20241129
<SEC-HEADER>0001104659-24-124097.hdr.sgml : 20241129
<ACCEPTANCE-DATETIME>20241129162118
ACCESSION NUMBER:		0001104659-24-124097
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20241126
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241129
DATE AS OF CHANGE:		20241129

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Transcode Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001829635
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				811065054
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40363
		FILM NUMBER:		241516576

	BUSINESS ADDRESS:	
		STREET 1:		6 LIBERTY SQUARE
		STREET 2:		#2382
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
		BUSINESS PHONE:		857-301-6857

	MAIL ADDRESS:	
		STREET 1:		6 LIBERTY SQUARE
		STREET 2:		#2382
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02109
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2429720d2_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:rnaz="http://transcodetherapeutics.com/20241126">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_rnaz_transcodetherapeutics.com_20241126 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20241126_20241126 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0001829635 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000005" name="dei:EntityCentralIndexKey">0001829635</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rnaz-20241126.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-11-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001829635</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-26</xbrli:startDate>
        <xbrli:endDate>2024-11-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>



<p style="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b>&#160;</p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_909_edei--DocumentType_c20241126__20241126_zOYrO3mp59ae"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_909_edei--DocumentPeriodEndDate_c20241126__20241126_znnxn6Jr98pd"><ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">November 26, 2024</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span></span></b>&#160;</p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityRegistrantName_c20241126__20241126_zJcCdfPiXSeg"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000012" name="dei:EntityRegistrantName">TRANSCODE THERAPEUTICS, INC.</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20241126__20241126_zEiqdyubJhD2"><ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_908_edei--EntityFileNumber_c20241126__20241126_z8KkxmjlYY66"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000014" name="dei:EntityFileNumber">001-40363</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20241126__20241126_zFk9vCbrhaVc"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000015" name="dei:EntityTaxIdentificationNumber">81-1065054</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or
                                    other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">of incorporation)</p></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Commission</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">File Number)</p></td>
    <td style="vertical-align: bottom"><b>&#160;</b></td>
    <td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification No.)</p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TransCode
Therapeutics, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20241126__20241126_zCGkLaWDKoK"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000016" name="dei:EntityAddressAddressLine1">6 Liberty Square</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20241126__20241126_zIKpvk0w2aE8"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000017" name="dei:EntityAddressAddressLine2">#2382</ix:nonNumeric></span></b> <br/>
<b><span id="xdx_90D_edei--EntityAddressCityOrTown_c20241126__20241126_zmREfweKzzq4"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000018" name="dei:EntityAddressCityOrTown">Boston</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20241126__20241126_zlUbWrSxyddb"><ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt-sec:stateprovnameen" id="Fact000019" name="dei:EntityAddressStateOrProvince">Massachusetts</ix:nonNumeric></span></b> <span style="font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20241126__20241126_zhf940Cy7d3d"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000020" name="dei:EntityAddressPostalZipCode">02109</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">(Address
of principal executive offices, including zip code)</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_902_edei--CityAreaCode_c20241126__20241126_zqrIxLhRbCT6"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000021" name="dei:CityAreaCode">857</ix:nonNumeric></span></b><b>)
<span id="xdx_90C_edei--LocalPhoneNumber_c20241126__20241126_z7ybfgXAuw05"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000022" name="dei:LocalPhoneNumber">837-3099</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_901_edei--WrittenCommunications_c20241126__20241126_zCOApWOFbpg8"><ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act (17&#160;CFR 230.425) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_902_edei--SolicitingMaterial_c20241126__20241126_z8BM1zEEwCLj"><ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17&#160;CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_904_edei--PreCommencementTenderOffer_c20241126__20241126_zANuEm4pNlv3"><ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17&#160;CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20241126__20241126_zthLBHO0uxXf"><ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17&#160;CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 38%; text-align: center"><b>Title of each class</b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 20%; text-align: center"><b>Trading Symbol(s)</b></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 38%; text-align: center"><b>Name of each exchange on which <br/>
registered</b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--Security12bTitle_c20241126__20241126_zjqxqWC5JQQ8"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000027" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--TradingSymbol_c20241126__20241126_zeP51aLSdyH5"><ix:nonNumeric contextRef="AsOf2024-11-26" id="Fact000028" name="dei:TradingSymbol">RNAZ</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>The<span id="xdx_90D_edei--SecurityExchangeName_c20241126__20241126_ziCjDOq4iaod"> <ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Capital Market</b></span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule&#160;12b-2 of the Securities
Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Emerging growth company&#160;&#160;<span style="font-family: Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20241126__20241126_zIRFmTinNX5e"><ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt:booleantrue" id="Fact000030" name="dei:EntityEmergingGrowthCompany">x</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_904_edei--EntityExTransitionPeriod_c20241126__20241126_zFhwD9YyHxq9"><ix:nonNumeric contextRef="AsOf2024-11-26" format="ixt:booleanfalse" id="Fact000031" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>






<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0.75pt">&#160;</p>

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0.75pt"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0.75pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><b>Item 3.03&#8239;&#8239;&#8239; &#8239;&#8239;Material Modifications
to Rights of Security Holders.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">To the extent required by Item 3.03 of Form&#160;8-K, information regarding the Reverse Split
(as defined below) contained in Item 5.03 of this Current Report on Form&#160;8-K is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><b>Item 5.03&#8239;&#8239;&#8239;&#8239;&#8239;Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.</b></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;26, 2024, TransCode Therapeutics,&#160;Inc.,
(the &#8220;Company&#8221;) filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the &#8220;Certificate
of Amendment&#8221;) to its Amended and Restated Certificate of Incorporation to effect a 1-for-33 reverse stock split (the &#8220;Reverse
Split&#8221;) of the Company&#8217;s issued and outstanding shares of common stock, par value $0.0001 per share (the &#8220;Common Stock&#8221;),
as of 12:01 a.m.&#160;Eastern Time on December&#160;4, 2024 (the &#8220;Effective Time&#8221;). Beginning with the opening of trading
on December&#160;4, 2024, the Company&#8217;s Common Stock is expected to trade on the Nasdaq Capital Market on a split-adjusted basis
under a new CUSIP, number 89357L 402. The Company&#8217;s Common Stock will continue to trade under the symbol &#8220;RNAZ.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At a Special Meeting of Stockholders held on November&#160;22,
2024, the Company&#8217;s stockholders granted the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) the discretion to effect
the Reverse Split at a ratio of any whole number between 1-for-10 and 1-for-40, with such ratio and the timing of the Reverse Split to
be determined by the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
a result of the Reverse Split, every thirty-three (33) shares of the Company&#8217;s Common Stock issued and outstanding as of the
Effective Time will automatically be converted into one (1)&#160;share of Common Stock, but without any change in the par value per
share. Proportional adjustments will be made to the number and exercise prices of shares of Common Stock issuable upon exercise of
the Company&#8217;s outstanding stock options and warrants. The Reverse Split will not change the number of authorized shares of
Common Stock. </span>Immediately after the Effective Time, after giving effect to the Reverse Split and the shares issued by the
Company in its previously announced private placement, the Company will have approximately 696,233 shares of Common Stock issued and
outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vstock Transfer LLC (&#8220;Vstock&#8221;), the
Company&#8217;s transfer agent, is acting as exchange agent for the Reverse Split. <span style="background-color: white">The Reverse Split
will affect all stockholders uniformly, except with respect to the treatment of fractional shares. </span>In lieu of issuing fractional
shares, stockholders of record who otherwise would be entitled to receive fractional shares will be entitled to rounding up of the fractional
share to the nearest whole number. Beneficial owners whose shares are held in &#8220;street name&#8221; through banks, brokers, custodians
or other nominees will have their holdings automatically adjusted without further action by such banks, brokers, custodians or other nominees,
who will be instructed by Vstock to give effect to the Reverse Split. However, these banks, brokers, custodians or other nominees may
have different procedures for processing the Reverse Split than those for registered stockholders. If a stockholder&#8217;s shares are
held by a bank, broker, custodian or other nominee and that stockholder has any questions in this regard, that stockholder is encouraged
to contact the bank, broker, custodian or other nominee holding their shares for more information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing description of the Certificate of
Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment,
which is filed as Exhibit&#160;3.1 to this Current Report on Form&#160;8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 7.01</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8239;&#8239;&#8239;&#8239;&#8239;Regulation FD Disclosure.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&#160;25, 2024, the Company issued
a press release announcing the Reverse Split and on November&#160;29, 2024, the Company issued a press release announcing the effective
date of the Reverse Split. Copies of the press releases are attached as Exhibit&#160;99.1 and 99.2 hereto, and incorporated herein by
reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 &#8239;&#8239;&#8239;&#8239;&#8239;Financial Statements and Exhibits.</b></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d)&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 8%"><b>Exhibit</b> <b><br/>
No.</b></td>
    <td style="text-align: justify; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: justify; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: justify"><a href="tm2429720d2_ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></a></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="tm2429720d2_ex3-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment to Amended and Restated Certificate of Incorporation of TransCode Therapeutics,&#160;Inc.</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: justify"><a href="tm2429720d2_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="tm2429720d2_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated November&#160;25, 2024.</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: justify"><a href="tm2429720d2_ex99-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></a></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><a href="tm2429720d2_ex99-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated November&#160;29, 2024.</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom; text-align: justify">&#160;</td>
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cover page&#160;from this Current Report on Form&#160;8-K formatted in Inline XBRL (included as Exhibit&#160;101). </span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: November&#160;29, 2024</span></td>
    <td colspan="2" style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TransCode Therapeutics,&#160;Inc.</b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2" style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 50%">&#160;</td>
    <td style="vertical-align: top; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Thomas A. Fitzgerald</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas A. Fitzgerald</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">Interim Chief Executive Officer and Chief Financial Officer</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt; text-align: justify">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OcwWhfAxqYgsRCJ6XXKMJd2R2c3yk/rLNiUaBobh3nOvEDOxpY1ukOGyKnM4Yds1yiGUWCOjuaJ3ZLt9Cv6WeNPWsTJufH9gRp5BzyShlMoLo7XXFqsUongu5VzGEC3TREJxEMFXz8jUukLjtGpAmQoKpo41OsXDlHBSLzLUDmPVGdlqMikswmiS3yCjhYQj9epJfLeQ55kIZuMEYsv06Lxr/XJoviSsG2x9nZ3o/wYfB/FKjw== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>tm2429720d2_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATE
OF AMENDMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>TO THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>CERTIFICATE
OF INCORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>TRANSCODE THERAPEUTICS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">TransCode Therapeutics,
Inc. (the &ldquo;Corporation&rdquo;), a corporation organized and existing under and by virtue of the General Corporation Law of the State
of Delaware (the &ldquo;DGCL&rdquo;), does hereby certify:</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">&nbsp;</TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: left">Pursuant to Section 242 of the DGCL, this Certificate of Amendment to the Amended and Restated Certificate
of Incorporation (this &ldquo;Certificate of Amendment&rdquo;) amends the provisions of the Amended and Restated Certificate of Incorporation
of the Corporation, as amended (the &ldquo;Charter&rdquo;).</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>2.</TD><TD STYLE="text-align: left">This Certificate of Amendment has been approved and duly adopted by the Corporation&rsquo;s Board of
Directors and stockholders in accordance with the provisions of Section 242 of the DGCL.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>3.</TD><TD STYLE="text-align: left">Upon this Certificate of Amendment becoming effective, the Charter is hereby amended as follows:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">ARTICLE IV of
the Charter is hereby amended by adding the following new paragraph at the end of such article:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&ldquo;D. DECEMBER
2024 REVERSE STOCK SPLIT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Effective at
12:01 AM, Eastern Time, on December 4, 2024 (the &ldquo;<B>December 2024 Split Effective Time</B>&rdquo;), every thirty-three (33) shares
of common stock issued and outstanding or held by the Corporation as treasury shares as of the December 2024 Split Effective Time shall
automatically, and without action on the part of the stockholders, be combined, reclassified and changed into one (1) validly issued,
fully paid and non-assessable share of common stock, without effecting a change to the par value per share of common stock, subject to
the treatment of fractional interests as described below (the &ldquo;<B>December 2024 Reverse Split</B>&rdquo;). Notwithstanding the immediately
preceding sentence, no fractional shares will be issued in connection with the combination effected by the preceding sentence. The Board
of Directors shall make provision for the issuance of that number of fractions of common stock such that any fractional share of a holder
otherwise resulting from the December 2024 Reverse Split shall be rounded up to the next whole number of shares of common stock. As of
the December 2024 Split Effective Time and thereafter, a certificate(s) representing shares of common stock prior to the December 2024
Reverse Split is deemed to represent the number of post-December 2024 Reverse Split shares into which the pre-December 2024 Reverse Split
shares were reclassified and combined. The December 2024 Reverse Split shall also apply to any outstanding securities or rights convertible
into, or exchangeable or exercisable for, common stock of the Corporation and all references to such common stock in agreements, arrangements,
documents and plans relating thereto or any option or right to purchase or acquire shares of common stock shall be deemed to be references
to the common stock or options or rights to purchase or acquire shares of common stock, as the case may be, after giving effect to the
December 2024 Reverse Split.&rdquo;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">&nbsp;</TD><TD STYLE="width: 0.25in">4.</TD><TD STYLE="text-align: left">This Certificate of Amendment shall become effective at 12:01 AM, Eastern Time, on December 4, 2024</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">*_*_*_*</P>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>IN
WITNESS WHEREOF</B>, the undersigned authorized officer of the Corporation has executed this Certificate of Amendment to the Amended and
Restated Certificate of Incorporation as of November 26, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: bold 10pt Times New Roman, Times, Serif">TRANSCODE THERAPEUTICS, INC.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> /s/ Thomas A Fitzgerald</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 42%"> Thomas A Fitzgerald</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Interim Chief Executive Officer and Chief Financial Officer</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>tm2429720d2_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><IMG SRC="tm2429720d2_ex99-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TransCode Therapeutics Announces 1-for-33 Reverse
Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Split designed to achieve compliance with Nasdaq
minimum bid price requirements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BOSTON, Nov. 25, 2024 -- TransCode Therapeutics,
Inc. (Nasdaq: RNAZ) (&#8220;TransCode&#8221; or the &#8220;Company&#8221;), the RNA Oncology Company&#8482; committed to more effectively
treating cancer using RNA therapeutics, today announced that its Board of Directors has approved a 1-for-33 reverse stock split. The reverse
stock split was approved by TransCode&#8217;s stockholders on November 22, 2024, and is intended to increase the per share trading price
of the Company's common stock to enable the Company to satisfy the minimum bid price requirement for continued listing on the Nasdaq Capital
Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 1-for-33 reverse stock split will automatically
convert thirty-three current shares of TransCode&#8217;s common stock into one new share of common stock. No fractional shares will be
issued in connection with the reverse stock split. In lieu of issuing fractional shares, stockholders of record who otherwise would be
entitled to receive fractional shares will be entitled to rounding up of the fractional share to the nearest whole number. The reverse
split will reduce the number of shares of common stock outstanding from 17,265,658 shares to approximately 523,202 shares. Proportional
adjustments also will be made to the exercise prices of TransCode&#8217;s outstanding stock options and warrants, and to the number of
shares issued and issuable under TransCode&#8217;s stock incentive plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vstock Transfer LLC will act as the exchange agent
for the reverse stock split. Stockholders of record are not required to take any action to receive post-split shares in book-entry. Stockholders
owning shares through a bank, broker, custodian or other nominee will have their positions automatically adjusted to reflect the reverse
stock split, subject to the holding entity&#8217;s particular processes; such stockholders will not be required to take any action in
connection with the reverse stock split. However, these banks, brokers, custodians or other nominees may have different procedures for
processing the reverse stock split than those for registered stockholders. If a stockholder holds shares of common stock with a bank,
broker, custodian or other nominee and has any questions in this regard, stockholders are encouraged to contact their bank, broker, custodian
or other nominee for more information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The effective date of the reverse stock split
has not yet been determined and will be announced by the Company at least two business days prior to its implementation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About TransCode Therapeutics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">TransCode is a clinical-stage oncology company focused on treating
metastatic disease. The Company is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics
based on its proprietary TTX nanoparticle platform. The company&#8217;s lead therapeutic candidate, TTX-MC138, is focused on treating
metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing
a portfolio of other first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic
access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2429720d2_ex99-1img02.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &#8220;forward-looking
statements&#8221; that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained
in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by
the use of words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221;
&#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;seek,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221;
&#8220;predict,&#8221; &#8220;project,&#8221; &#8220;target,&#8221; &#8220;aim,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221;
or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking
statements are based on the Company&#8217;s current expectations and are subject to inherent uncertainties, risks and assumptions that
are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove
to be accurate, including the Company&#8217;s expectations regarding the effect of the reverse stock split and its continued listing on
Nasdaq. These and other risks and uncertainties are described more fully in the sections titled &#8220;Risk Factors&#8221; and &#8220;Cautionary
Note Regarding Forward-Looking Statements&#8221; in the Company&#8217;s Annual Report on Form 10-K and other reports filed with the Securities
and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes
no duty to update such information except as required under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For more information, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TransCode Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tania Montgomery-Hammon, VP of Business Development</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">tania.montgomery@transcodetherapeutics.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal; text-transform: uppercase">TransCode
Therapeutics, Inc.&bull;6 Liberty Square #2382&bull;Boston, MA 02109</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>tm2429720d2_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2429720d2_ex99-2img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TransCode Therapeutics Announces Effective Date
for 1-for-33 Reverse Stock Split</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BOSTON, Nov. 29, 2024 -- TransCode Therapeutics,
Inc. (Nasdaq: RNAZ) (&#8220;TransCode&#8221; or the &#8220;Company&#8221;), the RNA Oncology Company&#8482; committed to more effectively
treating cancer using RNA therapeutics, today announced that its Board of Directors has approved an effective time at 12:01 a.m. Eastern
Standard Time December 4, 2024, for its 1-for-33 reverse stock split. TransCode&#8217;s common stock is expected to begin trading on a
split-adjusted basis on the Nasdaq Capital Market on December 4, 2024, under the current trading symbol, &#8220;RNAZ.&#8221; The reverse
stock split was approved by TransCode&#8217;s stockholders and Board of Directors on November 22, 2024, and is intended to increase the
per share trading price of the Company's common stock to enable the Company to meet the minimum bid price requirement for continued listing
on the Nasdaq Capital Market. There is no assurance that TransCode&#8217;s common stock will meet all Nasdaq requirements for continued
listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As previously announced, the 1-for-33 reverse
stock split will automatically convert thirty-three current shares of TransCode&#8217;s common stock into one new share of common stock.
No fractional shares will be issued in connection with the reverse stock split. In lieu of issuing fractional shares, stockholders of
record who otherwise would be entitled to receive fractional shares will be entitled to rounding up of the fractional share to the nearest
whole number. The reverse split will reduce the number of shares of outstanding common stock from 17,265,658 shares to approximately 696,233
shares which latter number includes shares sold in the private placement announced November 27, 2024. Proportional adjustments also will
be made to the exercise prices of TransCode&#8217;s outstanding stock options and warrants, and to the number of shares issuable under
TransCode&#8217;s stock incentive plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Vstock Transfer LLC will act as the exchange agent
for the reverse stock split. Stockholders of record are not required to take any action to receive post-split shares in book-entry. Stockholders
owning shares through a bank, broker, custodian or other nominee will have their positions automatically adjusted to reflect the reverse
stock split, subject to the holding entity&#8217;s particular processes; such stockholders will not be required to take any action in
connection with the reverse stock split. However, these banks, brokers, custodians or other nominees may have different procedures for
processing the reverse stock split than those for registered stockholders. If a stockholder holds shares of common stock with a bank,
broker, custodian or other nominee and has any questions in this regard, stockholders are encouraged to contact their bank, broker, custodian
or other nominee for more information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the reverse stock split, the
Company's CUSIP number will change to 89357L402 as of 12:01 a.m. Eastern Standard Time on December 4, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About TransCode Therapeutics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">TransCode is a clinical-stage oncology company focused on treating
metastatic disease. The Company is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics
based on its proprietary TTX nanoparticle platform. The Company&#8217;s lead therapeutic candidate, TTX-MC138, is focused on treating
metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing
a portfolio of other first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic
access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains
&#8220;forward-looking statements&#8221; that are subject to substantial risks and uncertainties. All statements, other than
statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained
in this press release may be identified by the use of words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221;
&#8220;contemplate,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221;
&#8220;seek,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221;
&#8220;project,&#8221; &#8220;target,&#8221; &#8220;aim,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or
the negative of these words or other similar expressions, although not all forward-looking statements contain these words.
Forward-looking statements are based on the Company&#8217;s current expectations and are subject to inherent uncertainties, risks
and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future
events that may not prove to be accurate, including the Company&#8217;s expectations regarding the effect of the reverse stock split
and its continued listing on Nasdaq. These and other risks and uncertainties are described more fully in the sections titled
&#8220;Risk Factors&#8221; and &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; in the Company&#8217;s Annual
Report on Form 10-K and other reports filed with the Securities and Exchange Commission. Forward-looking statements contained in
this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For more information, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TransCode Therapeutics, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tania Montgomery-Hammon, VP of Business Development</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">tania.montgomery@transcodetherapeutics.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rnaz-20241126.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaKMebOdzZR+GYkxtmB1bVlKnyMvE+V0nSX0YzhmgXoB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:rnaz="http://transcodetherapeutics.com/20241126" elementFormDefault="qualified" targetNamespace="http://transcodetherapeutics.com/20241126">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://transcodetherapeutics.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="rnaz-20241126_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="rnaz-20241126_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>rnaz-20241126_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>rnaz-20241126_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://transcodetherapeutics.com/role/Cover" xlink:href="rnaz-20241126.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://transcodetherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2429720d2_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2429720d2_ex99-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ 8$# 2(  A$! Q$!_\0
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MPK1J"MHQ*[(]!U^P\2Z8NHZ;(\EN7* NA4Y'7@UIU%;VT%K%Y5O#'#'G.R-
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MLA96B^20CYB&7K]>].O-*LK^027$)9PNW<KLA*^AVD9'L>*N(BQHJ(H55&
M, "G?0+$%K:FV\S,KR%V!)?KT _I5BBBI&%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
5%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2429720d2_ex99-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2429720d2_ex99-1img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !3 %8# 2(  A$! Q$!_\0
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M_P"N0_DM:1;:9G))-$/_  K;P=_T +7_ ,>_QKIX88[>"."% D4:A$4=  ,
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<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2429720d2_ex99-2img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2429720d2_ex99-2img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ 8$# 2(  A$! Q$!_\0
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MPK1J"MHQ*[(]!U^P\2Z8NHZ;(\EN7* NA4Y'7@UIU%;VT%K%Y5O#'#'G.R-
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MLA96B^20CYB&7K]>].O-*LK^027$)9PNW<KLA*^AVD9'L>*N(BQHJ(H55&
M, "G?0+$%K:FV\S,KR%V!)?KT _I5BBBI&%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
5%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45208689405120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 26, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 26,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TRANSCODE THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001829635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-1065054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6 Liberty Square<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">#2382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">837-3099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RNAZ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MRGW?\9S3@[G8;(U]4!_T$K;A"VY>DIF"NWJN$HB(QUK(F"B^[CM#[_Z!=FQ
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]02P,$%
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MO-9.&G_FB^$_7G\!4$L! A0#%     @ J()]60=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "H@GU9
M=.)A4^X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " "H@GU9F5R<(Q &  "<)P  $P              @ ',
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *B"?5GM*Q>KK 0
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M2P$"% ,4    " "H@GU9)!Z;HJT   #X 0  &@              @ $4$@
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "H@GU999!Y
MDAD!  #/ P  $P              @ 'Y$@  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  !#%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2429720d2_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://transcodetherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>rnaz-20241126.xsd</File>
    <File>rnaz-20241126_lab.xml</File>
    <File>rnaz-20241126_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2429720d2_8k.htm">tm2429720d2_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2429720d2_8k.htm": {
   "nsprefix": "rnaz",
   "nsuri": "http://transcodetherapeutics.com/20241126",
   "dts": {
    "schema": {
     "local": [
      "rnaz-20241126.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "rnaz-20241126_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rnaz-20241126_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2429720d2_8k.htm"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 25
   },
   "report": {
    "R1": {
     "role": "http://transcodetherapeutics.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2429720d2_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2429720d2_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://transcodetherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001104659-24-124097-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-24-124097-xbrl.zip
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M +O))@5-34 D6(T!-!RT^3.E7HB8R9%)8#IG,=G]3/9@NUHZMTP -IM0&**
MJ+ [ [ HQ2A7(RGW L:=2#98[!=)U#-5M(5NT8",-MDP50'! 5@#Z"C5:#&?
M^9Q)EG@WCR6HR4-2/ _>0PFH=PM+C^TF,X X('2Z'0($R2#4C/()TIQ%7#SS
MVN,.,[Z5 ^!^QF-XA=(3Y1:J04UHHM49$A!@0WP"F#5"/Q3/I""NWN/)*T"J
M!B_$7<2Q/%!I^<]UPL@QV'ZKUBU='7:;3%F$ 9$$NP/X*94?] >D8M M"P6:
MZ1N:.O4/S70H--.@H9F^!YKE*P\$FI,W-/7$/S0G0Z$Y"1J:DW=!(SO>ZU@S
MDQ]OQ9*_VA[.!I5>D&E;M0)SD(6'2\M;'RPJ0*UG5(A/3/*%U:VX$_PE81&\
M9(;D7H !3%NI,;3AH6,WV,=/M2#6<5['FF)1WOLET3(_HTS3I'V(*33A0=(T
MUCNX%&J?2-SQ-,/TW\ESYXFX7>P%#ZMA*R0-97BHV.SU 5/$(!GDX\2ZQ%7=
MT+"^2F:4NWL%V&+K\ IPK3 ("&R.VJ\ %U=/"I'K;E:,"H*!$:%9[*R3+::J
M/JZ5A='%;4.M'LZ_UU+CXXNLLKO0NT?.X <$VA)7/0V9T[UME@?1XX IL]=S
M&<IUGJ[&JPP3J7WXKI4YF]E-.]5$K@N"Z%W336N:UN6.>_-7D61RSS.^V6Q9
M>9?']MP@H'/5RYTV=8];14'T?I<SDX12BYIBQU@L.$VB)$O8^A=Y\BD2;&N5
M3>0*"-B@IJ&M" (%T);)P4&(M-(Q!'>"* B)[(C\)4"56$C</CQ89_LNL2LH
M^@UK.&!E$)#TVC-AD0'CJ!:!BA"4Q_C%9IZF6R+>!(\EQ!-"H'D I)8^1)P@
MD[U0%8$^V5J0:"OGQ_WQ=+5,,FH[N6Q+G,U)@+EJ1C+*@V #,&6RD)<A_H".
MIW]9_17I*,?=?\.7 JODL8O]9L4ID'W*JG(%08=%S8%%$@0*L"^3AAN.2BDJ
MM#ZR4S7,6IICE+L"P&I+=WVC,(A.MSEJ??D;?>UIR+_<18_2% %>2+#+7 _]
M-I/F\%_7!(% A['624DI15KKXX6$PY2U[E\$K+TM M8]BX!UB(N ]=!%P-K;
M(D#OMD@1(L>EVQ5-UAA(3MBI=@U%AV63#XLT*%1@?^"8486@0XSKC)9YBC.5
MGE]L\OU?R0^65@(Z9SDMNVQ622UMHB 8Z7+62FM9))VKB9%2N^9B&R<9B0LS
M5PG#+$HPK=(CVJZ(]X<XHV6@^0J<'GT8# TSV<*I"-.Y#*O 0ZI+UY?2BP<P
M?B64_LSX*UL0G')&XN):BNU.4;?>[1,S/;:;#\T XB!P&N(0>'1&!8V?5!32
M8>65,"\D?>-TRS(L\G?)A6UD G1NR0%L-HDQ1 &18G<&$%*)4:'V\X)VD3VB
M6F05OSL$-A"2.WY=N].T\=:V51L0,YT&H7>XRYP?A[5Q$>7I%<N,J-^+2%[(
M%YSATAO87DCN^J7*+M/FVY0V;4 (=1H$WY^L8E2J&*R9\I8R1LSD4FO-.YX2
M-U3N$\>T++9SQU22@/"P^>K((".0UGIA8;'!E'[>I@DC*3P1&2JW+%@M-EEH
M2 )BP>8+8"&7(JWUPL+EAHBUG-Y^$OPU>RSSLX)M ]1NV>BTW&3$*@V(E2Y_
M #,Z!!4Q.J6N'WAVAX3B199%N*46J6-L0+,&,RU=2,! YEJT4!*IZRTW/$-+
MCKZF!&6/!%V6/T-7SP1?U./KET:B2+T04:S*68R%#:$NL?-?'0$-MWY[I*4,
M J1>>_#OD%012(<XIN96,BSJYW&YB7E&-N#;#OTAK@@::EYSU*</@J:!)DVF
M\K#FR74>B%2DSVQ&]>3V\!*O(7*\,K88-!;&-440C("VH&5Q_;<"_.3.VZYH
M$EU1CN&K+ V-XXQY;7M&LKR#(" "VJZ@%'FY$.5*+_W_&;,GL7W.HOV=X!$A
MZBFKM!JM^JZ_#8QVR\R;FM2D:5!H0)R]Q2] X*$*5*OC0VW&\GDQ3STTKK*Y
M\>AI\8CE ;S=9JF:0:4Q^"IX9Y#CVPL#&F#<9.B(" B] 3:A&PYY),I#/Z B
M&-6B/9V?I8<L@"3^O+\G#T2H]PZ69)=]ECMZZCC#&!#K^NQM<'/,D[G>P" @
M?*M;Z%0O1?4*T$H](U96@7Y3E:"\%MOOE]<W7<M/<K/>)/]:X93(+?\%4$L#
M!!0    ( *B"?5E_KI_69 <  .]7   5    <FYA>BTR,#(T,3$R-E]P<F4N
M>&ULS9S?<]HX$,??;^;^!Q_W# 1H>Y<TN4Y"0X=IVN1"VM[=2T?8 C21)4:2
M ]Q??Y(-E!^6O+D';_*0$+.2]OM96?9:DL_?+5,>/5&EF107C4[KI!%1$<N$
MB>E%X\NH>3GJ#X>-2!LB$L*EH!<-(1OO_OCYI\C^G/_2;$8#1GER%KV7<7,H
M)O)M])FD]"SZ0 55Q$CU-OI*>.:.R 'C5$5]F<XY-=1^431\%KUN=5^-HV83
M4.]7*A*IOMP/M_7.C)GKLW9[L5BTA'PB"ZD>=2N6*:S"D2$FT]O:3I8GZY^B
M^#EGXO',_1H332/+2^BSI687#=?NNME%KR75M-T].>FT__IT,XIG-"5-)ARW
MF#8VI5PM9>4ZIZ>G[?S;C>F1Y7*L^*:-7GOCSK9F^RT+V.]XHMF9SMV[D3$Q
M>=@KFXF\%NZ_YL:LZ0XU.]UFK]-:ZJ2Q@9\35)+3>SJ)W%\;O6VK1A&A;8^C
M9F;[RYQFAL5Y]-K.LMV7MG=:M_,Z9HI.+AI*D']M4]U7G4[WC6OHUSTCLYK;
M7JJ9ZV2-J+WGQ%Q1387)==_8 WM%Z-+8OD63346N_?_EIF'&E5QWHT[4='TN
M2VW#]F-AN?9JXQ>7\9XKW,5&'NC>]/,\ IK&K:E\:B>4V4AT>^Z#@]++@=A_
MON<-78ZU]3PVFYHX&5.>U__=VAR8M&OP:D/BP=98[M2^Q:%/NQ&\5'$D54*5
M9;VIBZAX+V['779MT9X392MJQC/&MR&?*)GZZ*Q)2(^CNZ!L$_70O+3M)\Z'
M 2?3<IP')D">'0R@I6JPB+ZG.E9L[KA4@-VS!/+MHO(MT58SYLVY<T^GS/GK
M7'$78NH.AL<%3Q$@^![F2!%4BQ2!2R$RPN_I7*H*\/N60-ZO,'F7:4/"_&=&
ME*&*KR"DCXR!L%]CPO8H1.+]X.[7F.,# 7YL#23^!O7&PZ,1"?EH1CEWR1T1
MH%Y>9@_$_ALF=K_.%P#^^LE=W^VE!<Y^IP@0_^\O!?^16J0(W%'%9&(OZ0K
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M              "  1A"  !T;3(T,CDW,C!D,E]E>#DY+3(N:'1M4$L%!@
0   '  < T $  !=-      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>tm2429720d2_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rnaz-20241126.xsd" xlink:type="simple"/>
    <context id="AsOf2024-11-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001829635</identifier>
        </entity>
        <period>
            <startDate>2024-11-26</startDate>
            <endDate>2024-11-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-11-26" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2024-11-26" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-11-26" id="Fact000005">0001829635</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-11-26" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-11-26" id="Fact000011">2024-11-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-11-26" id="Fact000012">TRANSCODE THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-11-26" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-11-26" id="Fact000014">001-40363</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-11-26" id="Fact000015">81-1065054</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-11-26" id="Fact000016">6 Liberty Square</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-11-26" id="Fact000017">#2382</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-11-26" id="Fact000018">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-11-26" id="Fact000019">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-11-26" id="Fact000020">02109</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-11-26" id="Fact000021">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-11-26" id="Fact000022">837-3099</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-11-26" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-11-26" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-11-26" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-11-26" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-11-26" id="Fact000027">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-11-26" id="Fact000028">RNAZ</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-11-26" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-11-26" id="Fact000030">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2024-11-26" id="Fact000031">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
